[1]洪盈盈 赵晓宏 周庆元 柳围堤 薛开禄.外周血microRNA-146a的表达与糖尿病 周围神经病变的关系[J].国际内分泌代谢杂志,2018,38(01):6-9，14.[doi:10.3760/cma.j.issn.1673-4157.2018.01.002]
　Hong Yingying,Zhao Xiaohong,Zhou Qingyuan,et al.Relationship between the expression of microRNA-146a in peripheral blood and diabetic peripheral neuropathy[J].International Journal of Endocrinology and Metabolism,2018,38(01):6-9，14.[doi:10.3760/cma.j.issn.1673-4157.2018.01.002]
点击复制

外周血microRNA-146a的表达与糖尿病 周围神经病变的关系()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年01期
页码:
6-9，14
栏目:
论著
出版日期:
2018-01-20

文章信息/Info

Title:
Relationship between the expression of microRNA-146a in peripheral blood and diabetic peripheral neuropathy
作者:
洪盈盈 赵晓宏 周庆元 柳围堤 薛开禄
723000 西安交通大学医学院附属3201医院内分泌科
Author(s):
Hong Yingying; Zhao Xiaohong;  Zhou Qingyuan; Liu Weidi;  Xue Kailu.
Department of Endocrinology, The 3201 Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an 723000,China
关键词:
2型糖尿病;  糖尿病周围神经病变;  microRNA-146a
Keywords:
Type 2 diabetes mellitus;  Diabetic peripheral neuropathy;  microRNA-146a
DOI:
10.3760/cma.j.issn.1673-4157.2018.01.002
摘要:
目的 分析外周血microRNA-146a(miR-146a)表达水平与糖尿病周围神经病变(DPN)的关系。方法 回顾性分析2015年5月—2016年7月西安交通大学医学院附属3201医院内分泌科收治的90例2型糖尿病(T2DM)患者的临床资料,分为T2DM合并DPN组(42例)与T2DM组(48例)。所有患者入院后均采集外周血标本,测定外周血单核细胞(PBMCs)中miR-146a的表达水平,并收集其基线资料情况。测定患者右侧腓神经运动神经传导速度(MCV)、感觉神经传导速度(SCV),计算密歇根糖尿病神经病变评分(MNSI)。采用Pearson相关性分析法探讨各指标与miR-146a表达的相关性,采用logistic回归分析研究miR-146a表达的影响因素,应用受试者工作特征(ROC)曲线下面积(AUC)探讨miR-146a对T2DM发生DPN的预测价值。结果 与T2DM组相比,T2DM合并DPN组病程长,HbA1c、 尿白蛋白/肌酐比值(UAlb/Cr)升高,而腓神经MCV、SCV、MNSI以及miR-146a表达水平降低(t=3.586～15.143,P均<0.05)。miR-146a水平与病程、空腹血糖、HbA1c、MNSI呈负相关(r=-0.531、-0.621、-0.551、-0.662,P均<0.05),与MCV、SCV呈正相关(r=0.791、0.622,P均<0.05)。 MCV(OR=1.198,95%CI:1.021～1.398,P<0.05)、SCV(OR= 2.851,95%CI:1.551～5.261,P<0.05)是影响miR-146a表达的独立危险因素,病程(OR=0.162,95%CI: 0.081～0.264,P<0.05)、MNSI(OR=0.416,95%CI:0.071～0.456,P<0.05)为其保护因素。 miR-146a预测DPN的敏感性为83.91%,特异性为62.12%(95%CI:0.567～0.841,P=0.008)。结论 T2DM合并DPN患者外周血miR-146a表达水平较低,且SCV、 MCV为影响miR-146a表达的独立危险因素,同时miR-146a对T2DM患者DPN的发生有较高的预测价值。
Abstract:
Objective To analyze the relationship between the expression of microRNA-146a(miR-146a)in peripheral blood and diabetic peripheral neuropathy(DPN).Methods The clinical data of 90 patients with type 2 diabetes mellitus(T2DM)treated in the Department of Endocrinology of the 3201 Hospital affiliated to Medical College of Xi'an Jiaotong University from May 2015 to July 2016 were retrospectively analyzed. The patients were divided into T2DM with DPN group(n=42)and T2DM group(n=48). Peripheral blood of all patients were collected to test the expression of miR-146a in peripheral blood mononuclear cells(PBMCs). The baseline data were collected. The motor nerve conduction velocity(MCV)and sensory nerve conduction velocity(SCV)of right peroneal nerve were tested, and the Michigan diabetic neuropathy score(MNSI)were calculated. The relationship between each index and miR-146a expression were explored by Pearson correlation analysis. Logistic regression analysis was used to study the influencing factors of miR-146a expression. The area under the receiver operating curve(ROC)was used to investigate the predictive value of miR-146a in the development of DPN in T2DM.Results Compared with T2DM group, the course of disease was longer, the level of HbA1c and urinary albumin/creatinine ratio were higher, the MCV and SCV of peroneal nerve and MNSI as well as the expression of miR-146 were lower in T2DM with DPN group (t=3.586-15.143,all P<0.05). The expression of miR-146a was negatively correlated with course of disease, fasting blood glucose, HbA1c, MNSI(r=-0.531,-0.621,-0.551,-0.662,all P<0.05), and was positively correlated with MCV and SCV(r=0.791,0.622,all P<0.05). The MCV(OR=1.198,95%CI:1.021-1.398,P<0.05)and SCV(OR= 2.851,95%CI:1.551-5.261,P<0.05)were independent risk factors of the expression of miR-146a, while the course of disease(OR=0.162,95%CI: 0.081-0.264,P<0.05)and MNSI (OR=0.416,95%CI:0.071-0.456,P<0.05)were the protective factors. The sensitivity and specificity of miR-146a in predicting DPN were 83.91% and 62.12%, respectively(95%CI:0.567-0.841, P=0.008).Conclusions The expression of miR-146a is lower in patients with T2DM and DPN. SVC and MVC are independent risk factors for miR-146a and miR-146a is of high value in predicting the development of DPN in patients with T2DM.

参考文献/References:


[1] Zheng X,Zhu S,Chang S,et al. Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: role of NF-kappa B signaling[J].Eur J Pharmacol,2013,pii: S0014-2999(13)00793-0. DOI:10.1016/j.ejphar.2013.10.034.
[2] 王国凤,徐宁,杨涛,等.外周血单个核细胞miR-146a在2型糖尿病周围神经病变发病机制中的作用[J].中华内分泌代谢杂志,2016,32(7):552-555. DOI:10.3760/cma.j.issn.1000-6699.2016.07.006.
[3] Choi SK,Galán M,Kassan M,et al.Poly(ADP-ribose)polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus[J].Hypertension,2012,59(5):1060-1068.DOI:10.1161/HYPERTENSIONAHA.111.190140.
[4] 徐向进, 潘长玉, 田慧,等. WHO及美国糖尿病学会糖尿病诊断标准在老年人群中应用的分析和评估[J].中华内分泌代谢杂志,2002,18(5):357-361.DOI:10.3760/j.issn:1000-6699.2002.05.008.
[5] 陈晓文,马红英,陈勇伟,等.2型糖尿病患者周围神经病变危险因素分析[J]. 中华糖尿病杂志,2014, 22(12):1057-1059. DOI:10.3969/j.issn.1006-6187.2014.12.001.
[6] 张春风, 谢云, Priyadarshini Yonzon,等. 密歇根筛查量表对糖尿病神经病变的诊断价值[J].天津医药, 2013, 41(3):208-211.DOI:10.3969/j.issn.0253-9896.2013.03.005.
[7] 宋虎平,朱琦,吴琼,等.缺氧诱导因子1α特异性小干扰RNA对早期糖尿病大鼠视网膜白细胞黏附及髓样细胞活性的影响[J].中华眼科杂志,2015,51(5):351-355.DOI:10.3760/cma.j.issn.0412-4081.2015.05.009.
[8] Cavarretta E,Chiariello GA,Condorelli G.Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: per aspirin ad astra[J].Eur Heart J,2013,34(44):3400-3402.DOI:10.1093/eurheartj/eht032.
[9] Kulkarni SS,Salehzadeh F,Fritz T,et al.Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus[J].Metabolism,2012,61(2):175-185.DOI:10.1016/j.metabol.2011.06.014.
[10] 赵宏伟,南新帅,童宗中,等.糖尿病足与糖尿病视网膜病变相关性分析[J].解放军医药杂志,2016,28(9):17-20.DOI:10.3969/j.issn.2095-140X.2016.09.005.
[11] 林密,许诚楷,孔丹莉,等.长链非编码RNA与糖尿病相关性研究进展[J].国际遗传学杂志,2015,38(5):277-281.DOI:10.3760/cma.j.issn.1673-4386.2015.05.008.
[12] 李晓云,王立新,牛建一,等.miR-126在糖尿病大鼠脑缺血损伤组织中的表达及在血管再生中的意义[J].中华神经医学杂志,2016,15(9):908-912. DOI:10.3760/cma.j.issn.1671-8925.2016.09.007.
[13] Chen SS,Jiang T,Wang Y,et al. Activation of double-stranded RNA-dependent protein kinase inhibits proliferation of pancreatic β-cells[J].Biochem Biophys Res Commun,2014,443(3):814-820.DOI:10.1016/j.bbrc.2013.12.051.
[14] 陈根,秦旭平,李洁,等.微RNA-29与糖尿病心血管病变[J].中华生物医学工程杂志,2016,22(4):333-336.DOI:10.3760/cma.j.issn.1674-1927.2016.04.015.

相似文献/References:

[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
　Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
　Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
　Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(01):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
　Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
　Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(01):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
　Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
　Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(01):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
　Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(01):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[11]罗德钦,李智明,林慧,等.血清pannexin-1与2型糖尿病周围神经 病变的相关性研究[J].国际内分泌代谢杂志,2022,42(06):520.[doi:10.3760/cma.j.cn121383-20201214-12040]
　Luo Deqin,Li Zhiming,Lin Hui,et al.Serum pannexin-1 level and its clinical significance in patients with type 2 diabetes mellitus and diabetic peripheral neuropathy[J].International Journal of Endocrinology and Metabolism,2022,42(01):520.[doi:10.3760/cma.j.cn121383-20201214-12040]

备注/Memo

备注/Memo:

通信作者:洪盈盈,Email:453033046@qq.com
更新日期/Last Update: 2018-01-30